Gufic Biosciences Statistics
Total Valuation
Gufic Biosciences has a market cap or net worth of INR 41.98 billion. The enterprise value is 45.17 billion.
Market Cap | 41.98B |
Enterprise Value | 45.17B |
Important Dates
The next estimated earnings date is Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | Sep 18, 2024 |
Share Statistics
Gufic Biosciences has 100.28 million shares outstanding. The number of shares has increased by 2.60% in one year.
Shares Outstanding | 100.28M |
Shares Change (YoY) | +2.60% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | 44.46% |
Owned by Institutions (%) | 5.60% |
Float | 24.73M |
Valuation Ratios
The trailing PE ratio is 48.18.
PE Ratio | 48.18 |
Forward PE | n/a |
PS Ratio | 5.11 |
PB Ratio | 7.88 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 52.30 |
EV / Sales | 5.55 |
EV / EBITDA | 30.83 |
EV / EBIT | 34.99 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 62.51 |
Debt / EBITDA | 2.27 |
Debt / FCF | n/a |
Interest Coverage | 8.11 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 10.43% |
Revenue Per Employee | 5.46M |
Profits Per Employee | 579,267 |
Employee Count | 1,491 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +34.85% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +34.85% |
50-Day Moving Average | 366.02 |
200-Day Moving Average | 333.84 |
Relative Strength Index (RSI) | 61.09 |
Average Volume (20 Days) | 22,917 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Gufic Biosciences had revenue of INR 8.14 billion and earned 863.69 million in profits. Earnings per share was 8.69.
Revenue | 8.14B |
Gross Profit | 4.27B |
Operating Income | 1.29B |
Pretax Income | 1.16B |
Net Income | 863.69M |
EBITDA | 1.47B |
EBIT | 1.29B |
Earnings Per Share (EPS) | 8.69 |
Balance Sheet
The company has 134.84 million in cash and 3.33 billion in debt, giving a net cash position of -3.19 billion or -31.85 per share.
Cash & Cash Equivalents | 134.84M |
Total Debt | 3.33B |
Net Cash | -3.19B |
Net Cash Per Share | -31.85 |
Equity (Book Value) | 5.33B |
Book Value Per Share | 53.13 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 52.39%, with operating and profit margins of 15.85% and 10.60%.
Gross Margin | 52.39% |
Operating Margin | 15.85% |
Pretax Margin | 14.21% |
Profit Margin | 10.60% |
EBITDA Margin | 17.99% |
EBIT Margin | 15.85% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.03%.
Dividend Per Share | 0.10 |
Dividend Yield | 0.03% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.60% |
Shareholder Yield | -2.57% |
Earnings Yield | 2.08% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 29, 2002. It was a forward split with a ratio of 10.
Last Split Date | Oct 29, 2002 |
Split Type | Forward |
Split Ratio | 10 |